We're thrilled to announce that the results of our survey conducted amongst 197 oncology nurses in the USA have been published in the journal Healthcare and also presented as a poster at the Oncology Nursing Society meeting (April 10-14 2025). Listen to co-author Natasha Pinheiro as she explains the rationale for the survey and discusses key results.

Access the paper online here: The Evolving Role of the Oncology Nurse in the United States of America.  

The survey results highlight: 

  • How roles and responsibilities of cancer nurses have evolved since the COVID-19 pandemic and how their workload has increased  
  • The importance of self-care initiatives and education to support nurses in their complex, busy and emotionally charged work environment, and to help retain existing nurses and attract new ones  

Read the publication to gain insights into this important role.  Download the slide kit and poster for a summary of the results.  

Clinical takeaways 

  • Oncology nurses' roles in the USA are expanding and evolving. Some changes have brought opportunities to improve patient care and make it more accessible  
  • There is a need to decrease the workload and emotional demands that are currently affecting nurses. They demand enhanced education and training 
  • Joint efforts from societies and institutions to work collaboratively and make existing education more accessible could improve this workforce’s current challenges 
  • Explore how the role of oncology nurses in the USA is continuously changing and to evaluate this from the nurses’ perspective.  
  • Understand how changes made during the pandemic may have irreversibly altered aspects of nursing.  

Nina Grenon is a nurse practitioner caring for patients with Gastrointestinal Cancers for the past 22 years, 14 at the Dana-Farber Cancer Institute and the previous 8 years at the Massachusetts General Hospital Cancer Center. She is adjunct faculty at Simmons College, School of Nursing and Health Sciences and serves as a clinical preceptor for nurse practitioner students at Yale University, Simmons College and MGH Institute of Health Professions. She serves on the North America Neuroendocrine Association Tumor Society, regional education committee. Nina Grenon is a frequent national and regional lecturer in colon and pancreatic cancer, published a number of articles in the nursing implication in the management of side effects in patients treated for colon cancer. She is currently on the Oncology Nursing Society Congress Planning Team for 2020. Her research and quality improvement interest include patient and care taker education, specific intervention delivered by front line nurses and the early integrating of palliative care in patients with advanced gastrointestinal malignancies specifically pancreatic cancer.

Natasha A. Pinheiro is an adult-gerontological primary care nurse practitioner working with the solid tumor gastrointestinal medical oncology group at Memorial Sloan Kettering Cancer Center in New York. She completed her Bachelor Science in nursing from New York University and her masters of science in nursing, adult nurse practitioner form Long Island University. Ms. Pinheiro specializes in the medical management of patients with gastrointestinal cancers, focusing on colorectal cancers with hepatic arterial infusion pump therapy, upper GI and hepatobiliary cancers. She has served on multiple HCC advisory boards and has been a member of the Nursing Advisory Board of the Cholangiocarcinoma Foundation.

Karen Waldrop Karen Waldrop received her Bachelor of Nursing Science from Florida State University in 1987. Her nursing background includes Internal Medicine, Infectious Diseases, Cardiac Stepdown, and In-patient Multidisciplinary Research. Karen has found her passion in Oncology nursing where she operated since 2011, receiving the designation of Oncology Certified Nurse in 2017. Since January, 2018 Karen has been serving as the GI Oncology Clinical Care Coordinator at the University of Alabama at Birmingham.

Brittni has been working as an Advanced Clinical Education Specialist for UPMC Hillman Cancer Center in Pittsburgh PA since 2017. She earned her Master’s in Nursing Administration from Waynesburg University, Waynesburg PA in 2014 and her Bachelor’s in Nursing from Carlow University, Pittsburgh PA. She has been working in oncology since 2010 with her initial nursing experience in critical care. Her oncology experience includes Clinical Research, Stem Cell Transplant, Management, and Education.

Programme summary
Watch the video now
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer.
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Bayer.
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GI NURSES CONNECT

GI NURSES CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

video Video
Oncology 
ADCs in HR+/HER2- metastatic breast cancer

Optimising treatment strategies and AE management

Experts
Dr Barbara Pistilli
Endorsed by
GRASP
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock MIN
  • calendar May 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca.
podcast Podcast

Episode

2

of 2

episode
Oncology 
The HER2 diagnostic and treatment landscape in NSCLC: Episode 2

Navigating common treatment scenarios in HER2-mutant non-small cell lung cancer

Experts
Dr Eric Singhi, Dr Isabel Preeshagul, Oncology Brothers (Moderators)
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 18 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Emerging molecular testing paradigms in NSCLC management

Experts
Prof. Frédérique Penault-Llorca, Prof. Mark Socinski
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
animated-video Animated Video
Oncology 
Elacestrant in ER+/HER2- metastatic breast cancer with ESR1-mut tumors

An overview of the EMERALD subgroup analyses

Experts
Prof. Javier Cortés
  • download Downloadable
    Resources
  • clock 8 MIN
  • calendar Apr 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
podcast Podcast

Episode

1

of 2

episode
Oncology 
The HER2 diagnostic and treatment landscape in NSCLC: Episode 1

A medical oncologist and a pathologist share their perspectives on best practices in identifying HER2-directed NSCLC

Experts
Prof. Fernando López-Ríos, MD, PhD, Dr Devika Das, Oncology Brothers (Moderators)
Endorsed by
ICAN international cancer advocacy network Biomarker Collaborative Exon20group
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Apr 2025

Educational programme supported by an Independent Educational Grant from Bayer.
micro-learning Micro learning

Module

3

of 3

module
Oncology 
The expanding role of immunotherapy in HCC

Module 3: Combining locoregional and systemic treatments in intermediate HCC

Experts
Prof. Aiwu Ruth He, Prof. Beau Toskich
Endorsed by
Global Liver Institute ELPA DiCE
Blue Faery
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Apr 2025

AstraZeneca has provided a sponsorship grant towards this independent programme.